Year archive

Zhaoke Ophthalmology Limited — 2025 filings

All 47 regulatory filings released by Zhaoke Ophthalmology Limited (6622) in 2025, sourced directly from the official regulator.

47 Filings

2025 Period

2025 filings (47)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - ENTERING INTO STRATEGIC PARTNERSHIP WITH TSH BIOPHARM TO COMMERCIALIZE BRIMOCHOL PF IN TAIWAN REGION Regulatory Filings	2025-12-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-01	English
VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION OF PAN-90806 APPROVED BY NMPA AND MARKETING AUTHORIZATION FOR EPINASTINE HCl EYE DROP OBTAINED FROM NMPA Regulatory Filings	2025-11-24	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AGREEMENT WITH PT FERRON TO COMMERCIALIZE BRIMOCHOL PF IN INDONESIA Regulatory Filings	2025-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Share Issue/Capital Change	2025-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-06	English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM Report Publication Announcement	2025-09-19	English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM Report Publication Announcement	2025-09-19	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-19	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2025-09-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 Interim / Quarterly Report H1 2025	2025-08-28	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-08-14	English
VOLUNTARY ANNOUNCEMENT - MEDICAL DEVICE REGISTRATION CERTIFICATE OBTAINED FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION FOR TONO-i FOR INTRAOCULAR PRESSURE MEASUREMENT Regulatory Filings	2025-08-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-04	English
VOLUNTARY ANNOUNCEMENT - ORPHAN DRUG DESIGNATION RECEIVED FROM THE U.S FDA FOR MELPHALAN TARGETING PEDIATRIC RETINOBLASTOMA Regulatory Filings	2025-07-30	English
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF NEW DRUG APPLICATION FOR NVK002 (ATROPINE SULPHATE EYE DROPS 0.02%) FOR THE TREATMENT OF MYOPIA PROGRESSION IN CHILDREN Regulatory Filings	2025-07-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-02	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Governance Information	2025-07-02	English
CHANGE IN COMPOSITION OF THE NOMINATION COMMITTEE Board/Management Information	2025-07-02	English
NOMINATION COMMITTEE - TERMS OF REFERENCE Governance Information	2025-06-30	English
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF BIOLOGICS LICENSE APPLICATION FOR TAB014 FOR THE TREATMENT OF wAMD Regulatory Filings	2025-06-12	English
VOLUNTARY ANNOUNCEMENT - FDA CLEARANCE OF IND APPLICATION FOR CsA OPHTHALMIC GEL Regulatory Filings	2025-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-02	English
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF NEW DRUG APPLICATION FOR CsA OPHTHALMIC GEL Regulatory Filings	2025-05-19	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 16, 2025 Declaration of Voting Results & Voting Rights Announcements	2025-05-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-06	English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM Report Publication Announcement	2025-04-24	English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM Report Publication Announcement	2025-04-24	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 16, 2025 Proxy Solicitation & Information Statement	2025-04-24	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-24	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND Proxy Solicitation & Information Statement	2025-04-24	English
Environmental, Social and Governance Report 2024 Environmental & Social Information	2025-04-24	English
2024 Annual Report Annual Report FY 2024	2025-04-24	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLED IN THE ADDITIONAL PHASE III CLINICAL TRIAL OF CYCLOSPORINE A (CsA) OPHTHALMIC GEL Regulatory Filings	2025-04-17	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO THREE DISTRIBUTION AGREEMENTS WITH INTERPHARMA TO COMMERCIALIZE NVK002, BRIMOCHO TM PF AND SIX GLAUCOMA DRUGS IN THAILAND Regulatory Filings	2025-04-16	English
VOLUNTARY ANNOUNCEMENT - UPDATES ON BRIMOCHOL TM PF FOR PRESBYOPIA Regulatory Filings	2025-04-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-03	English
CONNECTED TRANSACTION ANNOUNCEMENT RENEWAL OF THE LEASE AGREEMENT Regulatory Filings	2025-04-01	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 AND DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCT Earnings Release FY 2024	2025-03-24	English
NOTICE OF BOARD MEETING Regulatory Filings	2025-03-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-06	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AGREEMENT WITH AFT PHARMACEUTICALS TO COMMERCIALIZE BRIMOCHOL TM PF IN AUSTRALIA AND NEW ZEALAND Regulatory Filings	2025-01-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-03	English
VOLUNTARY ANNOUNCEMENT - NMPA ACCEPTANCE OF ABBREVIATED NEW DRUG APPLICATION FOR NVK002 FOR TREATMENT OF MYOPIA PROGRESSION IN CHILDREN Regulatory Filings	2025-01-02	English
VOLUNTARY ANNOUNCEMENT - POSITIVE TOP-LINE RESULTS FROM TAB014 PHASE III CLINICAL TRIAL FOR THE TREATMENT OF wAMD Regulatory Filings	2025-01-02	English